Guided Patient Care: Troy Watson provides compassionate, hands-on guidance that encourages accountability and confidence
3,4 American Association of Clinical Endocrinology guidelines recommend treatment with GLP-1RA in T2DM patients with coexisting ASCVD, high-risk for ASCVD, heart failure, or chronic kidney disease regardless of their glycemic control due to their organ protective effects
Adults with a body mass index of at least 27 kg/m2 and glycated hemoglobin levels between 7 and 10% who had been diagnosed with type 2 diabetes for at least 180 days prior to screening were included in the double-blind, double-dummy study
Try to weigh yourself at the same time of day, in similar clothing, to get consistent results
[1] [2] This symptom typically peaks during the first few weeks after initiation or dose escalation and generally diminishes with continued therapy